Inherited Retinal Disease
Belite Bio Inc. focuses on clinical research in Stargardt disease, with attention to adolescent populations affected by progressive retinal degeneration and atrophic lesion growth.
- Stargardt disease
- Adolescent retinal degeneration
- Atrophic lesion progression
The sponsor’s work in this area centers on preserving visual function and addressing the course of inherited macular disease.
Geographic Atrophy
The clinical portfolio includes studies in geographic atrophy, a late-stage form of age-related macular degeneration characterized by progressive loss of retinal tissue and enlargement of GA lesions.
- Geographic atrophy
- Age-related macular degeneration
- Retinal lesion enlargement
Research activity in this domain reflects interest in slowing structural retinal damage and monitoring disease progression in the macula.
Ophthalmic Safety and Tolerability
Belite Bio Inc. also studies the systemic and ocular safety profile of therapies used in retinal disease, with emphasis on long-term tolerability in patients with chronic eye conditions.
- Systemic safety
- Ocular tolerability
- Long-term treatment monitoring
This area supports continued evaluation of treatment suitability for extended use in inherited and degenerative retinal disorders.
